−10.01 MUSD
6.59 M
About Akari Therapeutics Plc
Sector
Industry
CEO
Jacques Rachelle Suzanne
Website
Headquarters
Boston
Founded
2004
ISIN
US00972G2075
FIGI
BBG003PMV495
Akari Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Nomacopan, is a second-generation complement inhibitor. The company was founded on October 7, 2004 and is headquartered in Boston, MA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
